2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Revenue | HK$7.1B | HK$24B | HK$16B | HK$12B | HK$8.8B |
Cost of Revenue | HK$2.6B | HK$11B | HK$7.5B | HK$6.7B | HK$5.3B |
Gross Profit | HK$4.5B | HK$13B | HK$8.2B | HK$5.2B | HK$3.4B |
Gross Profit % | 63% | 54% | 52% | 44% | 39% |
R&D Expenses | HK$0.27 | HK$0.52 | HK$0.45 | HK$0.49 | HK$0 |
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Net Income | HK$1.7B | HK$9.6B | HK$5.7B | HK$5.8B | HK$4.8B |
Dep. & Amort. | HK$186M | HK$186M | HK$181M | HK$198M | HK$160M |
Def. Tax | HK$0 | HK$0 | HK$0 | HK$0 | HK$0 |
Stock Comp. | HK$0 | HK$0 | HK$0 | HK$0 | HK$0 |
Chg. in WC | HK$3.7B | -HK$10B | -HK$652M | -HK$2.5B | -HK$910M |
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Cash | HK$6.1B | HK$3.6B | HK$3.6B | HK$14B | HK$1.8B |
ST Investments | HK$38B | HK$41B | HK$41B | HK$30B | HK$45B |
Cash & ST Inv. | HK$44B | HK$44B | HK$45B | HK$44B | HK$46B |
Receivables | HK$7.4B | HK$9.5B | HK$8.8B | HK$11B | HK$0 |
Inventory | HK$31B | HK$23B | HK$21B | HK$16B | HK$16B |